LMT: Defense Budgets Are Real. So Is the Valuation Debate.

Lockheed Martin added +2.1% in the recent session, and the move wasn’t a surprise to anyone watching institutional flow into large-cap defense. But the more interesting question isn’t why it moved — it’s whether the underlying fundamentals justify continued positioning here, or whether the easy money has already been made.

Start with the macro. The FY2026 NDAA was signed into law authorizing $900.6 billion in defense spending — roughly $8 billion above what the White House originally requested. Total projected FY2026 outlays, once supplementals are included, are running near $954 billion. That’s not a policy debate anymore. That’s a procurement cycle with legal authorization behind it. The structural bid under defense primes isn’t hypothetical.

Now the company. For full-year 2025, Lockheed reported revenue of $75.06 billion, up 5.64% year-over-year. Q4 2025 alone came in at $20.32 billion — a 9.1% YoY jump — with EPS of $5.80 beating the $5.75 consensus. The Missiles and Fire Control segment surged 18% in Q4, F-35 deliveries accelerated from 110 aircraft in 2024 to 191 in 2025, and backlog hit a record $193.6 billion, up 10% from the prior year. The 2026 revenue guide is $77.5B–$80B, implying roughly 5% growth.

Here’s where it gets complicated. Net income for full-year 2025 actually declined 5.98% despite the revenue growth. Q1 2026 EPS of $6.44 missed the $6.74 forecast. Free cash flow went negative at -$291 million in Q1, tied to an ERP implementation issue management expects to resolve by Q2. Citi recently cut its price target to $571 from $675, keeping a Neutral rating. The stock trades near 26x trailing earnings on roughly 5% annual revenue growth expectations — not a screaming value proposition at current levels around $525.

The options market reflects that tension. With the 52-week range spanning $410.11 to $692.00, LMT has compressed significantly off its highs. IV positioning is muted relative to the range — consistent with a stock in consolidation, not one pricing in a catalyst. For traders who believe the Q2 FCF recovery materializes and the Golden Dome missile defense program (Lockheed was awarded Space-Based Interceptor development contracts in May 2026) drives contract acceleration, a defined-risk bull structure — long call spread targeting the $560–$580 range into Q2 earnings — captures upside with limited premium at risk. For those skeptical of the valuation at 26x, a bear put spread or short delta hedge against a long equity position manages the downside if FCF disappointments continue.

The institutional bid is real. The spending authorization is real. The backlog is real. What’s less clear is whether LMT — at current multiples, with earnings pressure and a stock still 24% off its 52-week high — has the catalyst density to sustain a meaningful move higher before Q2 results land on July 28, 2026. That’s the question the +2.1% move doesn’t answer.

• FY2025 Revenue: $75.06B (+5.64% YoY)
• Q4 2025 EPS: $5.80 vs. $5.75 est. | Revenue: $20.32B (+9.1% YoY)
• Q1 2026 EPS: $6.44 — missed $6.74 estimate
• 2026 Revenue Guide: $77.5B–$80B
• Backlog: $193.6B (record, +10% YoY)
• FCQ Q1 2026: -$291M (ERP-related; resolution expected Q2)
• 52-Week Range: $410.11–$692.00 | Current: ~$525
• Consensus: Hold | Avg. Price Target: ~$602
• Next Earnings: July 28, 2026
• Bull Structure: Long call spread $560/$580 into Q2 earnings (defined risk)
• Bear Structure: Bear put spread or short delta hedge if FCF misses continue
• Key Catalyst to Watch: Q2 FCF recovery + Golden Dome / Space-Based Interceptor contract flow